Unique metabolic markers detect over 50% of children affected by autism spectrum disorder

(Bioscribe) Blood sample analyses from the Children's Autism Metabolome Project have now reproducibly identified unique metabolic signatures in over 50% of the participating children with autism. This is an important step towards developing a metabolomics test panel that could biologically screen for ASD risk in children as young as 18 months. Analysis of other potential blood-based biomarkers using CAMP study samples remains ongoing, aimed at detecting a yet higher percentage of children at ris...